Skip to Main Content

Author Details

Matthew Elliott
College of Life Sciences, University of Dundee
2003
14
14
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
21466816Comparison of the specificity of Trk inhibitors in recombinant and neuronal assays.Neuropharmacology2011
21513497ATP site-directed inhibitors of protein kinase CK2: an update.Curr Top Med Chem2011
19432557Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.Biochem J2009
18588507The selectivity of inhibitors of protein kinase CK2: an update.Biochem J2008
17133643Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors.Chembiochem2007
17850214The selectivity of protein kinase inhibitors: a further update.Biochem J2007
14962382Interactions of LY333531 and other bisindolyl maleimide inhibitors with PDK1.Structure2004
15566294Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole.J Med Chem2004
15461466Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study.Biochemistry2004
14710188D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a.EMBO Rep2004
12534346The specificities of protein kinase inhibitors: an update.Biochem J2003
12816539Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).Biochem J2003
12892559Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition.Biochem J2003
  • 1 - 14 of 14

Recommended Authors

Reza Beheshti Zavareh
The Scripps Research Institute
Career Start Year 2008
Number of shared co-authors 0
Ahmed Aman
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2007
Number of shared co-authors 1
Alok R Singh
university of california san diego Department of Pediatrics, University of California
Career Start Year 2007
Number of shared co-authors 1
Andriy G Golub
OTAVA LTD
Career Start Year 2006
Number of shared co-authors 0
Thomas B Sundberg
Cutaneous Biology Research Center
Career Start Year 2006
Number of shared co-authors 0
Jamal C Saeh
Oncology R&D
Career Start Year 2005
Number of shared co-authors 0
Anang A Shelat
St. Jude Children's Research Hospital
Career Start Year 2003
Number of shared co-authors 3
Oliver Hantschel
Institute of Physiological Chemistry, University of Marburg 35032 Marburg Germany .
Career Start Year 2003
Number of shared co-authors 0
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 4
Nancy Su
Career Start Year 2000
Number of shared co-authors 0
Rima Al-Awar
Ontario Institute for Cancer Research, University Avenue
Career Start Year 1999
Number of shared co-authors 1
Michael Zinda
Repare Therapeutics Inc.
Career Start Year 1998
Number of shared co-authors 0
Stephan C Sch??rer
Institute for Data Science and Computing, University of Miami
Career Start Year 1998
Number of shared co-authors 1
Jian Jin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 1998
Number of shared co-authors 4
Monika A Davare
Oregon Health Sciences University
Career Start Year 1998
Number of shared co-authors 0
Jack Taunton
University of California san francisco
Career Start Year 1996
Number of shared co-authors 49
Kate F Byth
Oncology R&D
Career Start Year 1996
Number of shared co-authors 0
Nathanael S Gray
Harvard Medical School
Career Start Year 1996
Number of shared co-authors 8
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 0
Mark M Moasser
Helen Diller Family Comprehensive Cancer Center
Career Start Year 1994
Number of shared co-authors 2
Rengul Cetin-Atalay
Middle East Technical University
Career Start Year 1994
Number of shared co-authors 0
Michael Ohlmeyer
Atux Iskay LLC
Career Start Year 1993
Number of shared co-authors 3
Philip A Cole
Brigham and Women's Hospital, Blavatnik Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 3
Zhong-Yin Zhang
Center for Cancer Research, and Institute for Drug Discovery, Purdue University
Career Start Year 1990
Number of shared co-authors 1
David Uehling
Ontario Institute for Cancer Research, University Avenue
Career Start Year 1989
Number of shared co-authors 0
Joel Morris
National Cancer Institute
Career Start Year 1986
Number of shared co-authors 0
Stuart L Schreiber
Broad Institute
Career Start Year 1985
Number of shared co-authors 3
Stefan Knapp
Institute of Pharmaceutical Chemistry, Goethe University
Career Start Year 1983
Number of shared co-authors 6
Jonathan A Pachter
Laufer Center for Physical and Quantitative Biology, Stony Brook University
Career Start Year 1979
Number of shared co-authors 2
Paul Workman
The Institute of Cancer Research
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Dario R Alessi
University of Dundee
Co-authored papers 4
Charles James Hastie
University of Dundee
Co-authored papers 2
Hannes Braberg
University of California San Francisco
Co-authored papers 1
Jacqueline M Fabius
Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG)
Co-authored papers 1
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 1
Susana Flores
University of Miami
Co-authored papers 1
Lily Y-L Lee
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Daniel J Saltzberg
University of California san francisco
Co-authored papers 1
Rachel Toth
University of Dundee
Co-authored papers 1
Danish Memon
European Bioinformatics Institute
Co-authored papers 1
Mohd Anisul Karim
Wellcome Trust Sanger Institute
Co-authored papers 1
Eric Tse
School of Clinical Medicine, University of Hong Kong
Co-authored papers 1
Gregory E Merz
University of California san francisco
Co-authored papers 1
Zun Zar Chi Naing
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 1
Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 1
Nadia Herrera
University of California san francisco
Co-authored papers 1
Ming Sun
Columbia University
Co-authored papers 1
Loan Doan
University of California san francisco
Co-authored papers 1
Maliheh Safari
University of California san francisco
Co-authored papers 1
Anthony J Hodder
University of Sheffield
Co-authored papers 1
Justin T Biel
University of California san francisco
Co-authored papers 1
Ishan Deshpande
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers 1
Fengbo Zhou
Washington University School of Medicine
Co-authored papers 1
David E Gordon
Emory University
Co-authored papers 1
Tristan W Owens
University of California san francisco
Co-authored papers 1
Thomas Kehrer
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Kerry Burness
College of Life Sciences, University of Dundee
Co-authored papers 1
Elena Moreno
Icahn School of Medicine at Mount Sinai
Co-authored papers 1
David A Agard
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 1
Ajda Rojc
Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG)
Co-authored papers 1
Release 1.2